Kintor Pharmaceutical : Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China -Today at 04:54 am

Suzhou, August 22, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company...

Related Keywords

Suzhou ,Jiangsu ,China ,Kintor Pharma ,Yang Qinping ,Fudan University Huashan Hospital ,Kintor Pharmaceutical Limited Pharma ,Pharmaceutical Limited ,Professor Yang Qinping ,Youzhi Tong ,Chief Executive Officer ,Markets ,